Verve Therapeutics logo
VerifiedBiotechnology Research· Founded 2018

Verve Therapeutics

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is developing a new class of genetic medicines for cardiovascular disease with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The company's lead programs – VERVE-102, VERVE-201, and VERVE-301 – target the three lipoprotein drivers of atherosclerosis: low-density lipoproteins, triglyceride-rich lipoproteins, and lipoprotein(a). VERVE-102 is designed to permanently turn off the PCSK9 gene in the liver and is being developed initially for heterozygous familial hypercholesterolemia and ultimately to treat patients with established atherosclerotic cardiovascular disease (ASCVD) who continue to be impacted by high low-density lipoprotein cholesterol levels. VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for refractory hypercholesterolemia, where patients still have high low-density lipoprotein cholesterol despite treatment with maximally tolerated standard of care therapies, and homozygous familial hypercholesterolemia. VERVE-301 is designed to permanently turn off the LPA gene to reduce lipoprotein (a) levels. Lipoprotein (a) is a genetically validated, independent risk factor for ASCVD, ischemic stroke, thrombosis, and aortic stenosis.

7-day free trial · no credit card

HeadquartersBoston, United StatesEmployees185(201 to 500)Annual revenue$1M to <$10MFounded year2018Websitevervetx.comLinkedIn profileLinkedIn

Verified contacts

168

available on Kipplo

LinkedIn employees

185

201 to 500 range

Open roles

2

across 1 depts

Distinct roles

119

indexed titles

Tech stack

2

tools in use

Monthly traffic

1.7K

organic / mo

Hiring · 2 open positions across 1 departments

IT2

Sign up free to see all 168 verified contacts at Verve Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

168 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Verve Therapeutics

119 distinct titles indexed · top 10 shown.

  • 3()
  • 3associate scientist
  • 3director
  • 3scientist
  • 3senior research associate
  • 2' -
  • 2,,
  • 2associate director
  • 2associate director, clinical data management
  • 2principal scientist
  • +109more titles

Sign up to unlock all 168 contacts at Verve Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 168 verified contacts at Verve Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Verve Therapeutics | Kipplo Discover